APRI Apricus Biosciences, Inc.

0  -11%
Previous Close 1.54
Open 1.59
Price To book 0.00
Market Cap 10.61M
Shares 7,741,000
Volume 576,350
Short Ratio 1.71
Av. Daily Volume 389,156

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

NDA resubmission planned for 3Q 2017.
Erectile dysfunction
Phase 2b planned - seeking partnership
Secondary Raynaud's Phenomenon